The Lateral Lumbar Interbody (LLIF) procedure is a minimally invasive keyhole approach to perform thoracic and lumbar interbody fusions. The LLIF procedure is a newer alternative to the more traditional anterior (from the front) and posterior (from the back) lumbar interbody fusions.
The LLIF procedure permits the distraction of narrowed disc spaces, decompression of nerves, relief of pain and correction of deformities. The keyhole minimally invasive approach reduces postoperative pain, reduces blood loss, minimises scarring, shortens hospital stay and provides more rapid recovery from surgery. Additionally, the LLIF approach avoids scar tissue if a patient has had previous abdominal surgery or anterior or posterior spinal operations.
Lateral Lumbar Interbody Fusion is suitable for people with the following conditions:
Tell Mr Malham about any medical conditions or previous operations. Suppose you have a medical condition such as diabetes, heart problems, high blood pressure or asthma. In that case, Mr Malham may arrange for a specialist physician to see you for a pre-operative assessment and medical care following the neurosurgery.
Inform Mr Malham of the medication you are taking and/or have allergies to medications. You must stop using the following ten days pre-operatively:
You must stop using blood thinning medication (such as Warfarin) 3-5 days pre-operatively.
Preoperative Investigations will include:
The LLIF procedure is performed with the patient positioned usually on their right side, with the operating table slightly flexed to open up the space between the lower 12th rib and the iliac crest (hip bone). Then an image intensifier (intraoperative x-ray) is taken to visualise the exact location of the damaged/diseased disc level.
A small incision is made on the right side to allow a small dilator tube to be inserted through the muscles down to the spine.
The larger tube dilators are inserted over the guidance dilator, safely separating the side muscle over the spine (the psoas muscle flexing the hip). Using image intensifier guidance and nerve monitoring permits the tubes to be inserted into the spine, minimising the risk of any nerve damage/bruising to any nerves. With the tubes in place, a keyhole retractor is placed over them, locked in position to the surgical table and opened to provide keyhole visibility and instrument access to the disc space.
With the intervertebral disc visible, Mr Malham can safely remove the disc, decompress any nerves, and remove disc prolapses and boney narrowing/compression. Any deformity in the sagittal (front/back) or coronal (sideways) plane can be corrected with safe, careful distraction (separation) of the damaged disc level.
Then a new replacement disc made of PEEK (Poly Ether Ether Ketone; a space-age plastic) or titanium expandable cage, filled with artificial bone (bone morphogenic protein, BMP-2 Infuse) to avoid harvesting of iliac crest hip bone, is then inserted into the exposed, empty disc space to restore proper disc height and support the loads on that spine segment. The cage may be fixed with a titanium lateral plate and screws to the above and below vertebrae. Once the new cage (replacement disc) is in position and confirmed by the image intensifier, the retractor is closed and slowly and safely removed, allowing the separated muscles of the patient’s side to return to their normal position.
Final check x-rays are taken.
The one (or two) small skin incision is then closed in three layers with dissolvable sutures in the skin, and a wound dressing is applied.
LLIF has been shown to be an effective surgical option for stabilising the spine and reducing pain in many cases.
The specific risk of this procedure with the lateral keyhole approach is possible damage to the psoas muscle or surrounding structures, including the bowel and lumbar plexus nerves. Hence the main risk with the LLIF procedure is weakness, numbness and a burning sensation affecting the front of the right thigh, which is usually temporary and improves over 2-3 weeks. The risk is reduced by using nerve monitoring performed during the procedure. However, despite the utmost care, the patient may experience pain/numbness, and this should be notified to Mr Malham, who will treat the symptoms with steroid tablets or injection, nerve-dampening tablets called Lyrica or pain medication Endone/Oxycontin.
General risks of surgery and general anaesthetic are approximately 3% and include infection, bleeding, drug allergy, heart attack, stroke, DVT/PE, urinary tract infection and pneumonia.
If LLIF is recommended by a neurosurgeon and deemed necessary for addressing spinal instability or reducing pain, delaying the procedure may lead to prolonged suffering and potential worsening of the condition.
Delaying surgery could result in ongoing pain, reduced mobility, and decreased quality of life. Additionally, some spinal conditions may progress over time, potentially making the surgical procedure more complex if postponed.
Contact Us
Hours
Monday to Friday
9.00am – 5.00pm
*This may vary on occasions or the rooms may be briefly unattended.
All Rights Reserved | Greg Malham, Neurosurgeon, BSc MBChB DMed FRACS